Echocardiographic Follow-Up of Treated Patients With Carcinoid Syndrome
作者： Nicolas Mansencal , Emmanuel Mitry , Jean-Baptiste Bachet , Philippe Rougier , Olivier Dubourg
DOI: 10.1016/J.AMJCARD.2010.01.017
关键词: Carcinoid Heart Disease 、 Internal medicine 、 Gastroenterology 、 Circulatory system 、 Urinary system 、 Prospective cohort study 、 Cardiology 、 Endocrine Tumor 、 Carcinoid syndrome 、 Medicine 、 Pathology 、 Follow up studies 、 Rare disease 、 Cardiology and Cardiovascular Medicine
摘要: Carcinoid heart disease is a rare disease, and its prevalence uncertain. The aim of the present prospective study was to assess carcinoid using annual echocardiographic follow-up. We studied 80 consecutive patients presenting with histologically proven digestive endocrine tumor syndrome. All underwent conventional transthoracic studies measurement biologic markers. Right- left-sided score severity were systematically assessed. At baseline, right- 33% 8%, respectively. end follow-up, corresponding 53% 21%. correlations strong between urinary 5-hydroxyindoleacetic acid (5-HIAA) right-sided (r = 0.75, p
elsevier.com
sci-hub.se 参考文章(20)
L. Sideris, S. Hanna, D. Rayson, L. Siu, R. Reid, P. Poitras, A. Roy, A. Shah, L. Kvols, E. Chen, R. Wong, J. Rivera, J. Maroun, G. Bjarnason, C. Germond, W. Kocha, Guidelines for the diagnosis and management of carcinoid tumours. Part 1: the gastrointestinal tract. A statement from a Canadian National Carcinoid Expert Group. Current Oncology. ,vol. 13, pp. 67- 76 ,(2006) , 10.3747/CO.V13I2.84
M. B. JACOBSEN, S. NITTER-HAUGE, P. E. BRYDE, L. E. HANSSEN, Cardiac manifestations in mid-gut carcinoid disease European Heart Journal. ,vol. 16, pp. 263- 268 ,(1995) , 10.1093/OXFORDJOURNALS.EURHEARTJ.A060894
L Lundin, I Norheim, J Landelius, K Oberg, E Theodorsson-Norheim, Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities. Circulation. ,vol. 77, pp. 264- 269 ,(1988) , 10.1161/01.CIR.77.2.264
Nicolas Mansencal, Emmanuel Mitry, Rémy Pillière, Céline Lepère, Benoît Gérardin, Jérôme Petit, Iradj Gandjbakhch, Philippe Rougier, Olivier Dubourg, Prevalence of Patent Foramen Ovale and Usefulness of Percutaneous Closure Device in Carcinoid Heart Disease The American Journal of Cardiology. ,vol. 101, pp. 1035- 1038 ,(2008) , 10.1016/J.AMJCARD.2007.11.056
Paul A. Robiolio, Vera H. Rigolin, John S. Wilson, J. Kevin Harrison, Linda L. Sanders, Thomas M. Bashore, Jerome M. Feldman, Carcinoid Heart Disease Circulation. ,vol. 92, pp. 790- 795 ,(1995) , 10.1161/01.CIR.92.4.790
Sanjeev Bhattacharyya, Christos Toumpanakis, Martyn Evan Caplin, Joseph Davar, None, Analysis of 150 Patients With Carcinoid Syndrome Seen in a Single Year at One Institution in the First Decade of the Twenty-First Century The American Journal of Cardiology. ,vol. 101, pp. 378- 381 ,(2008) , 10.1016/J.AMJCARD.2007.08.045
P A Pellikka, A J Tajik, B K Khandheria, J B Seward, J A Callahan, H C Pitot, L K Kvols, Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients. Circulation. ,vol. 87, pp. 1188- 1196 ,(1993) , 10.1161/01.CIR.87.4.1188
Alain M. Bernheim, Heidi M. Connolly, Joseph Rubin, Jacob E. Møller, Christopher G. Scott, David M. Nagorney, Patricia A. Pellikka, Role of Hepatic Resection for Patients With Carcinoid Heart Disease Mayo Clinic Proceedings. ,vol. 83, pp. 143- 150 ,(2008) , 10.4065/83.2.143
Jacob E Møller, Heidi M Connolly, Joseph Rubin, James B Seward, Karen Modesto, Patricia A Pellikka, None, Factors associated with progression of carcinoid heart disease. The New England Journal of Medicine. ,vol. 348, pp. 1005- 1015 ,(2003) , 10.1056/NEJMOA021451
B.I. Gustafsson, O. Hauso, I. Drozdov, M. Kidd, I.M. Modlin, Carcinoid heart disease International Journal of Cardiology. ,vol. 129, pp. 318- 324 ,(2008) , 10.1016/J.IJCARD.2008.02.019